Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas

Biochemical and Biophysical Research Communications

Volumn 438, Issue 1, 2013, Pages 71-77

  Ponnaluri, V K Chaithanya ^a   Vavilala, Divya Teja ^a   Prakash, Swami ^a   Mukherji, Mridul ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Angiogenesis; Cancer; Hemangioblastomas; HIF signaling; Hypoxia; Inhibitor

Indexed keywords

DIGOXIN; DOXORUBICIN; HONOKIOL; HYPOXIA INDUCIBLE FACTOR;

ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; HEMANGIOBLASTOMA; HUMAN; HUMAN CELL; HYPOXIA; KIDNEY CARCINOMA; PIGMENT EPITHELIUM; PRIORITY JOURNAL; STEM CELL; STROMA CELL; VON HIPPEL LINDAU DISEASE;

ANGIOGENESIS; CANCER; EPO; ERYTHROPOIETIN; HEMANGIOBLASTOMAS; HIF; HIF SIGNALING; HRE; HYPOXIA; HYPOXIA RESPONSE ELEMENT; HYPOXIA-INDUCIBLE-FACTOR; INHIBITOR; JMJ-DOMAIN CONTAINING PROTEIN 1A; JMJD1A; PDGF; PHD; PLATELET-DERIVED GROWTH FACTOR; PROLYL HYDROXYLATION DOMAIN; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF; VHL; VON HIPPELE-LINDAU;

CELL HYPOXIA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMANGIOBLASTOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASTIC STEM CELLS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84881544542     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.07.028     Document Type: Article

References (29)

1. 2-regulated prolyl hydroxylation. Science 2001, 292:468-472.
2. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., Ratcliffe P.J. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001, 107:43-54.
3. Kim W.Y., Kaelin W.G. Role of VHL gene mutation in human cancer. J. Clin. Oncol. 2004, 22:4991-5004.
4. Chan C.C., Chew E.Y., Shen D., Hackett J., Zhuang Z. Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease. Mol. Vis. 2005, 11:697-704.
5. Park D.M., Zhuang Z., Chen L., Szerlip N., Maric I., Li J., Sohn T., Kim S.H., Lubensky I.A., Vortmeyer A.O., Rodgers G.P., Oldfield E.H., Lonser R.R. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells. PLoS Med. 2007, 4:e60.
6. Ma D., Zhang M., Chen L., Tang Q., Tang X., Mao Y., Zhou L. Hemangioblastomas might derive from neoplastic transformation of neural stem cells/progenitors in the specific niche. Carcinogenesis 2011, 32:102-109.
7. Glasker S., Li J., Xia J.B., Okamoto H., Zeng W., Lonser R.R., Zhuang Z., Oldfield E.H., Vortmeyer A.O. Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell. Cancer Res. 2006, 66:4167-4172.
8. Wong W.T., Liang K.J., Hammel K., Coleman H.R., Chew E.Y. Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease. Ophthalmology 2008, 115:1957-1964.
9. Wong W.T., Chew E.Y. Ocular von Hippel-Lindau disease: clinical update and emerging treatments. Curr. Opin. Ophthalmol. 2008, 19:213-217.
10. Vavilala D.T., Chaithanya Ponnaluri V.K., Vadlapatla R.K., Pal D., Mitra A.K., Mukherji M. Honokiol inhibits HIF pathway and hypoxia-induced expression of histone lysine demethylases. Biochem. Biophys. Res. Commun. 2012.
11. Zhang H., Qian D.Z., Tan Y.S., Lee K., Gao P., Ren Y.R., Rey S., Hammers H., Chang D., Pili R., Dang C.V., Liu J.O., Semenza G.L. Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc. Natl. Acad. Sci. USA 2008, 105:19579-19586.
12. Lee K., Qian D.Z., Rey S., Wei H., Liu J.O., Semenza G.L. Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells. Proc. Natl. Acad. Sci. USA 2009, 106:2353-2358.
13. Vavilala D.T., Ponnaluri V.K., Vadlapatla R.K., Pal D., Mitra A.K., Mukherji M. Honokiol inhibits HIF pathway and hypoxia-induced expression of histone lysine demethylases. Biochem. Biophys. Res. Commun. 2012, 422:369-374.
14. Ponnaluri V.K., Vadlapatla R.K., Vavilala D.T., Pal D., Mitra A.K., Mukherji M. Hypoxia induced expression of histone lysine demethylases: implications in oxygen-dependent retinal neovascular diseases. Biochem. Biophys. Res. Commun. 2011, 415:373-377.
15. Hu C.J., Wang L.Y., Chodosh L.A., Keith B., Simon M.C. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell. Biol. 2003, 23:9361-9374.
16. Iliopoulos O., Kibel A., Gray S., Kaelin W.G. Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med. 1995, 1:822-826.
17. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399:271-275.
18. Kondo K., Kim W.Y., Lechpammer M., Kaelin W.G. Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth. PLoS Biol. 2003, 1:E83.
19. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., Keshert E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998, 394:485-490.
20. Iliopoulos O., Levy A.P., Jiang C., Kaelin W.G., Goldberg M.A. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA 1996, 93:10595-10599.
21. Kondo K., Klco J., Nakamura E., Lechpammer M., Kaelin W.G. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 2002, 1:237-246.
22. Zimmer M., Doucette D., Siddiqui N., Iliopoulos O. Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors. Mol. Cancer Res. 2004, 2:89-95.
23. Guo X., Shi M., Sun L., Wang Y., Gui Y., Cai Z., Duan X. The expression of histone demethylase JMJD1A in renal cell carcinoma. Neoplasma 2011, 58:153-157.
24. Krieg A.J., Rankin E.B., Chan D., Razorenova O., Fernandez S., Giaccia A.J. Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth. Mol. Cell. Biol. 2010, 30:344-353.
25. Song H., Yin D., Liu Z. GDF-15 promotes angiogenesis through modulating p53/HIF-1alpha signaling pathway in hypoxic human umbilical vein endothelial cells. Mol. Biol. Rep. 2012, 39:4017-4022.
26. Rudnicki M., Faine L.A., Dehne N., Namgaladze D., Ferderbar S., Weinlich R., Amarante-Mendes G.P., Yan C.Y., Krieger J.E., Brune B., Abdalla D.S. Hypoxia inducible factor-dependent regulation of angiogenesis by nitro-fatty acids. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1360-1367.
27. Mathieu J., Zhang Z., Zhou W., Wang A.J., Heddleston J.M., Pinna C.M., Hubaud A., Stadler B., Choi M., Bar M., Tewari M., Liu A., Vessella R., Rostomily R., Born D., Horwitz M., Ware C., Blau C.A., Cleary M.A., Rich J.N., Ruohola-Baker H. HIF induces human embryonic stem cell markers in cancer cells. Cancer Res. 2011, 71:4640-4652.
28. 2 regulates stem cells through Wnt/beta-catenin signalling. Nat. Cell Biol. 2010, 12:1007-1013.
29. Mazumdar J., Dondeti V., Simon M.C. Hypoxia-inducible factors in stem cells and cancer. J. Cell. Mol. Med. 2009, 13:4319-4328.